Search results for "Short Communications"

showing 10 items of 11 documents

Evaluation of a rapid antigen detection test (Panbio™ COVID‐19 Ag Rapid Test Device) as a point‐of‐care diagnostic tool for COVID‐19 in a pediatric e…

2021

Abstract We evaluated the Panbio™ COVID‐19 Ag Rapid Test Device as a point‐of‐care diagnostic tool for COVID‐19 in 357 patients at a pediatric emergency department. Thirty‐four patients tested positive by reverse transcription polymerase chain reaction, of which 24 were positive by the antigen assay. The sensitivity and specificity of the assay were 70.5% and 100%, respectively.

Pediatric emergencyMale2019-20 coronavirus outbreakmedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)emergency departmentShort CommunicationShort CommunicationsSARS‐CoV‐2 RNA viral loadfield evaluationImmunologic TestsSensitivity and SpecificityCOVID-19 Serological TestingAntigenVirologyInternal medicineNasopharynxmedicineHumansProspective StudiesChildAntigens ViralPoint of carepediatric patientsbusiness.industrySARS-CoV-2clinical sensitivityCOVID-19InfantEmergency departmentVirologyTest (assessment)Reverse transcription polymerase chain reactionInfectious Diseasesrapid antigen assayPoint-of-Care TestingCOVID-19 Nucleic Acid TestingChild PreschoolFemalebusinessEmergency Service HospitalJournal of Medical Virology
researchProduct

Extreme Methylation Values of Imprinted Genes in Human Abortions and Stillbirths

2010

Imprinted genes play an important role in fetal and placental development. Using quantitative bisulfite pyrosequencing assays, we determined the DNA methylation levels at two paternally methylated (H19 and MEG3) and four maternally methylated (LIT1, NESP55, PEG3, and SNRPN) imprinted regions in fetal muscle samples from abortions and stillbirths. Two of 55 (4%) spontaneous abortions and 10 of 57 (18%) stillbirths displayed hypermethylation in multiple genes. Interestingly, none of 34 induced abortions had extreme methylation values in multiple genes. All but two abortions/stillbirths with multiple methylation abnormalities were male, indicating that the male embryo may be more susceptible t…

GeneticsRegulation of gene expressionMEG3FetusMusclesShort CommunicationsGene Expression Regulation DevelopmentalAbortion InducedMethylationDNA MethylationStillbirthBiologyfemale genital diseases and pregnancy complicationsPathology and Forensic MedicineGenomic ImprintingFetusPregnancyembryonic structuresDNA methylationHumansFemaleAlleleGenomic imprintingGenereproductive and urinary physiologyThe American Journal of Pathology
researchProduct

Qualitative assessment of SARS-CoV-2-specific antibody avidity by lateral flow immunochromatographic IgG/IgM antibody assay.

2020

Abstract Knowledge of the precise timing of SARS‐CoV‐2 infection may be of clinical and epidemiological relevance. The presence of low‐avidity IgGs has conventionally been considered an indicator of recent infection. Here, we carried out qualitative assessment of SARS‐CoV‐2‐specific antibody avidity using an urea (6M) dissociation test performed on a lateral flow immunochromatographic IgG/IgM device. We included a total of 76 serum specimens collected from 57 COVID‐19 patients, of which 39 tested positive for both IgG and IgM and 37 only for IgG. Sera losing IgG reactivity after urea treatment (n = 28) were drawn significantly earlier (P = .04) after onset of symptoms than those which prese…

AdultMaleCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Short CommunicationAntibody AffinityShort CommunicationsAntibodies ViralImmunoglobulin GSARS‐CoV‐2COVID-19 Serological Testing03 medical and health sciences0302 clinical medicineavidityVirologyurea dissociationMedicineHumansantibodiesIn patientAvidity030212 general & internal medicineQualitative ResearchAgedAged 80 and overImmunoassayCovid‐19medicine.diagnostic_testbiologybusiness.industrySARS-CoV-2COVID-19Middle AgedVirologySpecific antibodyInfectious DiseasesImmunoglobulin MImmunoglobulin MImmunoassayImmunoglobulin GImmunologybiology.protein030211 gastroenterology & hepatologyFemaleAntibodybusinessJournal of medical virology
researchProduct

Human platelet-rich plasma improves the nesting and differentiation of human chondrocytes cultured in stabilized porous chitosan scaffolds

2017

[EN] The clinical management of large-size cartilage lesions is difficult due to the limited regenerative ability of the cartilage. Different biomaterials have been used to develop tissue engineering substitutes for cartilage repair, including chitosan alone or in combination with growth factors to improve its chondrogenic properties. The main objective of this investigation was to evaluate the benefits of combining activated platelet-rich plasma with a stabilized porous chitosan scaffold for cartilage regeneration. To achieve this purpose, stabilized porous chitosan scaffolds were prepared using freeze gelation and combined with activated platelet-rich plasma. Human primary articular chond…

0301 basic medicineShort CommunicationsBiomedical EngineeringMedicine (miscellaneous)Human plateletCartilage tissue engineeringBiomaterialsChitosanlcsh:Biochemistry03 medical and health scienceschemistry.chemical_compoundTissue engineeringActivated platelet-rich plasmamedicinelcsh:QD415-436Cartilage repairPorosityCartilageRegeneration (biology)Stabilized porous chitosantechnology industry and agricultureAnatomyChondrogenesisequipment and supplies030104 developmental biologymedicine.anatomical_structurechemistryMAQUINAS Y MOTORES TERMICOSTERMODINAMICA APLICADA (UPV)Biomedical engineering
researchProduct

COVID-19 in people living with HIV: Clinical implications of dynamics of the immune response to SARS-CoV-2.

2020

ABSTRACT Background Little evidence on COVID‐19 in people living with HIV (PLWH) is currently available. Material and Methods We reported clinical and viro‐immunological data of all HIV‐positive patients admitted to our centre with COVID‐19 from March 1 to May 12,2020. Results Overall, five patients were included: all were virologically‐suppressed on antiretroviral therapy and CD4+ count was >350 cell/mm3 in all but two patients. Although all patients had evidence of pneumonia on admission, only one developed respiratory failure. SARS‐CoV‐2‐RNA was never detected from nasopharyngeal swabs in two patients, whereas, in the others, viral clearance occurred within a maximum of 43 days. IgG prod…

Malemedicine.medical_treatmentHIV InfectionsAntibodies ViralSeverity of Illness IndexImmunoglobulin GPiperazinesimmune responseSARS‐CoV‐20302 clinical medicine030212 general & internal medicinebiologyCoinfectionImmunosuppressionMiddle AgedInfectious DiseasesAnti-Retroviral AgentsCytokinesRNA ViralReverse Transcriptase Inhibitors030211 gastroenterology & hepatologyFemaleAntibodyHeterocyclic Compounds 3-RingRiskPyridonesShort CommunicationShort CommunicationsTransgender PersonsProinflammatory cytokine03 medical and health sciencesImmune systemCOVID‐19VirologySeverity of illnessOxazinesmedicineHumansHIV Integrase InhibitorsTenofovirbusiness.industrySARS-CoV-2medicine.diseaseHIV infectionVirologyAntibodies NeutralizingCD4 Lymphocyte CountImmunity HumoralCOVID-19 Drug TreatmentPneumoniaRespiratory failureImmunologybiology.proteinbusinessJournal of medical virology
researchProduct

Genetic Imbalances in Precursor Lesions of Endometrial Cancer Detected by Comparative Genomic Hybridization

2000

Endometrial hyperplasia is regarded as a precursor lesion of endometrioid adenocarcinomas of the endometrium. The genetic events involved in the multistep process from normal endometrial glandular tissue to invasive endometrial carcinomas are primarily unknown. We chose endometrial hyperplasia as a model for identifying chromosomal aberrations occurring during carcinogenesis. Comparative genomic hybridization (CGH) was performed on 47 formalin-fixed, paraffin-embedded specimens of endometrial hyperplasia using the microdissection technique to increase the number of tumor cells in the samples and reduce contamination from normal cells. CGH analysis revealed that 24 out of 47 (51%) samples ha…

AdultPathologymedicine.medical_specialtyGenotypeShort CommunicationsBiologyAdenocarcinomaPathology and Forensic MedicinemedicineAtypiaHumansMicrodissectionAgedNeoplasm StagingAged 80 and overEndometrial cancerNucleic Acid HybridizationHyperplasiaMiddle Agedmedicine.diseaseEndometrial hyperplasiaEndometrial NeoplasmsPhenotypeDysplasiaAdenocarcinomaFemalePrecancerous ConditionsComparative genomic hybridization
researchProduct

Validation of the STA-Liatest DDi assay for exclusion of proximal deep vein thrombosis according to the latest Clinical and Laboratory Standards Inst…

2018

: Recommended strategy for venous thromboembolism (VTE) diagnosis includes the use of sensitive D-dimer (DDi) assays along with pretest probability (PTP) assessment. The Clinical and Laboratory Standards Institute (CLSI) recently issued a guideline (US FDA endorsed) on DDi in VTE exclusion. Such guideline specifies the ideal D-dimer assay characteristics and target population. Demonstrate STA-LiatestD-Di performance combined with a PTP score for proximal deep vein thrombosis (pDVT) exclusion in a CLSI compliant study. International, multicenter, prospective nonrandomized, noninterventional clinical outcome management study conducted in a standard-of-care setting. DDi was measured in DVT-sus…

AdultMalemedicine.medical_specialtyDeep veinShort Communications030204 cardiovascular system & hematologySensitivity and SpecificityFibrin Fibrinogen Degradation ProductsSTA-Liatest DDi03 medical and health sciences0302 clinical medicineInternal medicineOutpatientsD-dimermedicineHumansProspective StudiesProspective cohort studyexclusiondeep venous thrombosisAgedVenous ThrombosisUnited States Food and Drug Administrationbusiness.industryImmunoturbidimetryHematologyGeneral MedicineGuidelineMiddle Agedmedicine.diseaseThrombosisUnited StatesPulmonary embolismClinical trialPre- and post-test probabilitymedicine.anatomical_structureD-dimerFemalebusiness030215 immunologyBlood Coagulation & Fibrinolysis
researchProduct

Fostering the healthcare workforce during the COVID ‐19 pandemic: Shared leadership, social capital, and contagion among health professionals

2020

Summary Health professionals managing patients with COVID‐19 disease are at high risk of contagion. All medical personnel involved in caring for patients need coordination, knowledge and trust. Empirical work on human resources has tended to focus on the effects of human resource practices on performance, whereas leadership and social interactions have been overlooked. Based upon interviews with medical staff working in specialised medical units, this study uses the social capital theory to examine relationships among shared leadership, social capital, and contagion rates. First, shared leadership was found to positively affect COVID‐19 contagion among health professionals. Second, by shari…

Infectious Disease Transmission Patient-to-ProfessionalHealth PersonnelShort CommunicationShort CommunicationsDiseaseShared leadershipAffect (psychology)Interviews as Topicshared leadershiphuman resource managementCOVID‐19Health carePandemicHumansHuman resourcesbusiness.industryHealth PolicyCOVID-19Public relationsHospitals PersonalLeadershipHuman resource managementsocial capitalbusinessSocial capitalThe International Journal of Health Planning and Management
researchProduct

Changes of morphogenic competence in mature Pinus sylvestris L. buds in vitro.

2002

The effects of season and cold storage on morphogenic competence in mature Pinus sylvestris buds were investigated. Peroxidase and polyphenol oxidase activity were measured as markers of oxidative metabolism. No growth in vitro was observed on explants detached from the end of January until the beginning of March. Brachioblasts, each with a couple of needles, formed on 11 % of the buds without macrostrobili that were detached in early April and introduced immediately into culture. Of the explants detached in late July, 15 % formed shoots with brachioblasts and needles. The lowest activity of peroxidase and polyphenol oxidase in pine buds was observed from the end of April until the beginnin…

biologyShort CommunicationsCold storagefood and beveragesPinus sylvestrisPlant SciencePolyphenol oxidase activityPinusPolyphenol oxidaseIn vitroCold TemperatureOxygenPlant LeavesCulture TechniquesBotanyShootbiology.proteinCatechol oxidaseOxidation-ReductionBiomarkersCatechol OxidasePlant ShootsPeroxidaseExplant culturePeroxidaseAnnals of botany
researchProduct

Retrospective screening for SARS-CoV-2 among influenza-like illness hospitalizations: 2018-2019 and 2019-2020 seasons, Valencia region, Spain

2021

Este artículo se encuentra disponible en la siguiente URL: https://onlinelibrary.wiley.com/doi/epdf/10.1111/irv.12899 En este artículo de investigación también participan: Juan Mollar-Maseres, Germán Schwarz-Chavarri, Sandra García-Esteban, Joan Puig-Barberà, Javier Díez-Domingo y F. Xavier López-Labrador. On 9 March 2020, the World Health Organization (WHO) Global Influenza Programme (GIP) asked participant sites on the Global Influenza Hospital Surveillance Network (GIHSN) to contribute to data collection concerning severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We re-analysed 5833 viral RNA archived samples collected prospectively from hospital admissions for influenza-lik…

Pulmonary and Respiratory Medicinemedicine.medical_specialty2019-20 coronavirus outbreakRT‐PCRSARS-CoV-2 (Virus) - Diagnóstico - 2018-2019 - España - Valencia (Comunidad Valenciana)EpidemiologyShort CommunicationSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)PopulationShort CommunicationscoronavirusData analysis.COVID-19 - Diagnóstico - 2019-2020 - España - Valencia (Comunidad Autónoma)medicine.disease_causeWorld healthCOVID‐19Influenza HumanPandemicmedicineHumansCOVID-19 - Diagnóstico - 2018-2019 - España - Valencia (Comunidad Autónoma)Influenza - Diagnosis - 2019-2020 - Spain - Valencia (Autonomous Community)Viral rnaGripe - Diagnóstico - 2018-2019 - España - Valencia (Comunidad Autónoma)influenza‐like‐illnesseducationRetrospective StudiesCoronaviruseducation.field_of_studyInfluenza-like illnessSARS-CoV-2business.industrySARS-CoV-2 (Virus) - Diagnosis - 2018-2019 - Spain - Valencia (Autonomous Community)COVID-19 (Disease) - Diagnosis - 2019-2020 - Spain - Valencia (Autonomous Community)Public Health Environmental and Occupational HealthCOVID-19virus diseasesCOVID-19 (Disease) - Diagnosis - 2018-2019 - Spain - Valencia (Autonomous Community)Análisis de datos.HospitalizationSARS-CoV-2 (Virus) - Diagnóstico - 2019-2020 - España - Valencia (Comunidad Valenciana)Infectious DiseasesInfluenza - Diagnosis - 2018-2019 - Spain - Valencia (Autonomous Community)SpainGripe - Diagnóstico - 2019-2020 - España - Valencia (Comunidad Autónoma)Emergency medicineSARS-CoV-2 (Virus) - Diagnosis - 2019-2020 - Spain - Valencia (Autonomous Community)Seasonsbusiness
researchProduct